Literature DB >> 33561611

Global incidence trends in head and neck cancer for HPV-related and -unrelated subsites: A systematic review of population-based studies.

Fabrício Dos Santos Menezes1, Gisele Aparecida Fernandes2, José Leopoldo Ferreira Antunes3, Luisa Lina Villa4, Tatiana Natasha Toporcov3.   

Abstract

In head and neck cancer (HNC), some subsites are associated with human papillomavirus (HPV) infection, whereas others are unrelated. Although studies have demonstrated the heterogeneity of HPV prevalence worldwide, its impacts on incidence trends in HNC are unknown. This systematic review examined the incidence trends for HPV-related HNC subsites, exploring patterns by geographic region, age group, sex, and race/ethnicity. We searched for publications on PubMed, Embase, and Scopus. Eligible articles included population-based studies that analyzed incidence trends for subsites classified as a proxy for HPV infection in HNC (hereafter referred to as HPV-related subsites). We retrieved 3,948 non-duplicate records, of which 31 were eligible articles, representing 18 countries and spanning almost fifty years. Overall, the incidence of HPV-related HNC subsites rose, while most of the HPV-unrelated subsites declined or remained stable. For HPV-related HNC subsites, incidence trends increased regardless of age group, highlighting a distinct global pattern between sexes. Also, similar peaks in increased risk were observed in recent cohorts from both Australia and the United States. There is a dramatic shift in the global trends of HNCs, characterized by the emerging burden in HNC for HPV-related subsites.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Epidemiology; Mouth neoplasms; Oropharyngeal neoplasms; Papillomavirus infections; Trends

Year:  2021        PMID: 33561611     DOI: 10.1016/j.oraloncology.2020.105177

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  9 in total

Review 1.  Post-diagnosis smoking cessation and survival of patients with head and neck cancer: a systematic review and meta-analysis.

Authors:  Saverio Caini; Marco Del Riccio; Virginia Vettori; Oriana D'Ecclesiis; Pierluigi Bonomo; Luca Giovanni Locatello; Viola Salvestrini; Oreste Gallo; Marta Tagliabue; Sara Raimondi; Calogero Saieva; Flavia Cozzolino; Benedetta Bendinelli; Sara Gandini
Journal:  Br J Cancer       Date:  2022-08-23       Impact factor: 9.075

2.  Factors Associated with Attitudes towards Preventing Head and Neck Cancer through HPV Vaccination in Poland: A Nationwide Cross-Sectional Survey in 2021.

Authors:  Wojciech Pinkas; Mateusz Jankowski; Waldemar Wierzba
Journal:  Vaccines (Basel)       Date:  2022-04-18

3.  LKB-1 Expression and High-Risk Histopathology are Independent Prognostic Factors for Patients with Oral Cavity Carcinoma.

Authors:  José F Carrillo; Christian Cruz-Romero; Alejandro Avilés-Salas; Liliana C Carrillo; Margarita C Ramírez-Ortega; Roberto Herrera-Goepfert; Rafael Vázquez-Romo; Gabriela Figueroa-González; Javier I Altamirano-García; Luis F Oñate-Ocaña
Journal:  Ann Surg Oncol       Date:  2022-03-23       Impact factor: 5.344

Review 4.  Regenerative Medicine Technologies to Treat Dental, Oral, and Craniofacial Defects.

Authors:  Jessica M Latimer; Shogo Maekawa; Yao Yao; David T Wu; Michael Chen; William V Giannobile
Journal:  Front Bioeng Biotechnol       Date:  2021-08-06

5.  Knowledge, opinions, and practices related to oral cancer prevention and oral mucosal examination among dentists in Moldova, Belarus and Armenia: a multi-country cross-sectional study.

Authors:  Olga Golburean; Maria Helene Hagen; Diana Uncuta; Marcela Tighineanu; Gayane Manrikyan; Izabella Vardanian; Christoffer Andresen; Bhavdeep Singh; Tatiana Porosencova; Irina Ivasiuc; Olga Cheptanaru; Marina Markaryan; Natalia Shakavets; Dipak Sapkota; Tine Merete Søland; Daniela-Elena Costea; Ferda Özkaya
Journal:  BMC Oral Health       Date:  2021-12-18       Impact factor: 2.757

6.  A Tumor-Infiltration CD8+ T Cell-Based Gene Signature for Facilitating the Prognosis and Estimation of Immunization Responses in HPV+ Head and Neck Squamous Cell Cancer.

Authors:  Yingning Wu; Lingzhang Meng; Kai Cai; Jingjie Zhao; Siyuan He; Jiajia Shen; Qiuju Wei; Zechen Wang; Suren Sooranna; Hengguo Li; Jian Song
Journal:  Front Oncol       Date:  2021-09-28       Impact factor: 6.244

7.  Positive Rate of Human Papillomavirus and Its Trend in Head and Neck Cancer in South Korea.

Authors:  Hyun Woong Jun; Yong Bae Ji; Chang Myeon Song; Jae Kyung Myung; Hae Jin Park; Kyung Tae
Journal:  Front Surg       Date:  2022-01-21

8.  Human papilloma virus integration sites and genomic signatures in head and neck squamous cell carcinoma.

Authors:  Juliette Mainguené; Sophie Vacher; Maud Kamal; Abderaouf Hamza; Julien Masliah-Planchon; Sylvain Baulande; Sabrina Ibadioune; Edith Borcoman; Wulfran Cacheux; Valentin Calugaru; Laura Courtois; Carole Crozes; Marc Deloger; Elodie Girard; Jean-Pierre Delord; Antoine Dubray-Vautrin; Linda Larbi Chérif; Celia Dupain; Emmanuelle Jeannot; Jerzy Klijanienko; Sonia Lameiras; Charlotte Lecerf; Anouchka Modesto; Alain Nicolas; Roman Rouzier; Esma Saada-Bouzid; Pierre Saintigny; Anne Sudaka; Nicolas Servant; Christophe Le Tourneau; Ivan Bièche
Journal:  Mol Oncol       Date:  2022-05-10       Impact factor: 7.449

9.  A clinician's dilemma: what should be communicated to women with oncogenic genital HPV and their partners regarding the risk of oral viral transmission?

Authors:  Ermelinda Monti; Giussy Barbara; Giada Libutti; Veronica Boero; Fabio Parazzini; Andrea Ciavattini; Giorgio Bogani; Lorenzo Pignataro; Beatrice Magni; Camilla Erminia Maria Merli; Paolo Vercellini
Journal:  BMC Womens Health       Date:  2022-09-17       Impact factor: 2.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.